Biomimetic nanomedicines for precise atherosclerosis theranostics

Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD), creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment. Biomimetic nanomedicines (bNMs) are moving closer to fulfilling this need, pushing back the frontier of nano-ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Ying, Lan, Xinmiao, Zhang, Yang, Fu, Chenxing, Liu, Lu, Cao, Feng, Guo, Weisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638499/
https://www.ncbi.nlm.nih.gov/pubmed/37969739
http://dx.doi.org/10.1016/j.apsb.2022.11.014
_version_ 1785146574762934272
author Tao, Ying
Lan, Xinmiao
Zhang, Yang
Fu, Chenxing
Liu, Lu
Cao, Feng
Guo, Weisheng
author_facet Tao, Ying
Lan, Xinmiao
Zhang, Yang
Fu, Chenxing
Liu, Lu
Cao, Feng
Guo, Weisheng
author_sort Tao, Ying
collection PubMed
description Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD), creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment. Biomimetic nanomedicines (bNMs) are moving closer to fulfilling this need, pushing back the frontier of nano-based drug delivery systems design. This review seeks to outline how these nanomedicines (NMs) might work to diagnose and treat atherosclerosis, to trace the trajectory of their development to date and in the coming years, and to provide a foundation for further discussion about atherosclerotic theranostics.
format Online
Article
Text
id pubmed-10638499
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106384992023-11-15 Biomimetic nanomedicines for precise atherosclerosis theranostics Tao, Ying Lan, Xinmiao Zhang, Yang Fu, Chenxing Liu, Lu Cao, Feng Guo, Weisheng Acta Pharm Sin B Review Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD), creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment. Biomimetic nanomedicines (bNMs) are moving closer to fulfilling this need, pushing back the frontier of nano-based drug delivery systems design. This review seeks to outline how these nanomedicines (NMs) might work to diagnose and treat atherosclerosis, to trace the trajectory of their development to date and in the coming years, and to provide a foundation for further discussion about atherosclerotic theranostics. Elsevier 2023-11 2022-11-15 /pmc/articles/PMC10638499/ /pubmed/37969739 http://dx.doi.org/10.1016/j.apsb.2022.11.014 Text en © 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Tao, Ying
Lan, Xinmiao
Zhang, Yang
Fu, Chenxing
Liu, Lu
Cao, Feng
Guo, Weisheng
Biomimetic nanomedicines for precise atherosclerosis theranostics
title Biomimetic nanomedicines for precise atherosclerosis theranostics
title_full Biomimetic nanomedicines for precise atherosclerosis theranostics
title_fullStr Biomimetic nanomedicines for precise atherosclerosis theranostics
title_full_unstemmed Biomimetic nanomedicines for precise atherosclerosis theranostics
title_short Biomimetic nanomedicines for precise atherosclerosis theranostics
title_sort biomimetic nanomedicines for precise atherosclerosis theranostics
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638499/
https://www.ncbi.nlm.nih.gov/pubmed/37969739
http://dx.doi.org/10.1016/j.apsb.2022.11.014
work_keys_str_mv AT taoying biomimeticnanomedicinesforpreciseatherosclerosistheranostics
AT lanxinmiao biomimeticnanomedicinesforpreciseatherosclerosistheranostics
AT zhangyang biomimeticnanomedicinesforpreciseatherosclerosistheranostics
AT fuchenxing biomimeticnanomedicinesforpreciseatherosclerosistheranostics
AT liulu biomimeticnanomedicinesforpreciseatherosclerosistheranostics
AT caofeng biomimeticnanomedicinesforpreciseatherosclerosistheranostics
AT guoweisheng biomimeticnanomedicinesforpreciseatherosclerosistheranostics

Ejemplares similares